Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Quick facts

Marketed products

• Descovy · Other
• Mpox Vaccine · Immunology
  The Mpox vaccine stimulates the immune system to produce antibodies and cellular immunity against Mpox virus antigens, providing protection against infection.
• PI-based regimen
• Silimarine · Other
• Unique · Other

Phase 3 pipeline

• Benzathine Penicilllin G · Infectious Disease
  Benzathine penicillin G inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and preventing peptidoglycan cross-linking.
• Protease Inhibitor/ritonavir · Infectious Disease
  This combination inhibits HIV protease while ritonavir acts as a pharmacokinetic booster to increase protease inhibitor levels in the bloodstream.
• Treatment and prophylaxis · Infectious Disease
  This drug works by inhibiting the replication of the human immunodeficiency virus (HIV).

Phase 2 pipeline

• Convalescent anti-SARS-CoV-2 MBT plasma · Infectious Diseases
  Convalescent anti-SARS-CoV-2 MBT plasma is a treatment that uses antibodies from recovered COVID-19 patients to help the body fight the virus.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia portfolio CI brief
• Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia pipeline updates RSS

Frequently asked questions about Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Related

• Descovy · Other
• Mpox Vaccine · Immunology
• PI-based regimen
• Silimarine · Other
• Unique · Other
• Sector hub: All tracked pharma companies